iRhythm Acquires VitalConnect for $237.5M to Expand Cardiac…

Event summary

iRhythm completed its acquisition of VitalConnect for $237.5M in cash plus up to 423,334 shares.
The deal expands iRhythm's cardiac monitoring capabilities into ambulatory, inpatient, and hospital-to-home care.
VitalConnect's platform adds multi-vitals monitoring and up to 30-day patient monitoring to iRhythm's portfolio.
iRhythm expects the acquisition to boost its revenue growth rate starting in 2027 while maintaining a 15% adjusted EBITDA margin target.
The transaction was funded from iRhythm's balance sheet, with an additional $10M in working capital provided to VitalConnect.

The big picture

iRhythm's acquisition of VitalConnect positions it to compete more broadly in the cardiac monitoring space, addressing a growing demand for continuous, multi-vitals monitoring across various care settings. The deal reflects a trend toward consolidating digital health technologies to create more comprehensive patient care solutions. With a $237.5M price tag, the acquisition underscores iRhythm's commitment to expanding its market presence and enhancing its service offerings.

What we're watching

Integration Challenges: How iRhythm will manage the integration of VitalConnect's technology and workforce to realize expected synergies.
Market Expansion: Whether the acquisition will successfully extend iRhythm's reach into inpatient and hospital-to-home care settings.
Financial Impact: The pace at which the acquisition will contribute to iRhythm's revenue growth and adjusted EBITDA margin.